Low dose versus high dose imatinib for gastrointestinal stromal tumors

J. Verweij; C. Blanke

doi:10.1038/ncpgasthep0086

Low dose versus high dose imatinib for gastrointestinal stromal tumors

Knight Cancer Institute

Research output: Contribution to journal › Short survey › peer-review

Original language	English (US)
Pages (from-to)	76-77
Number of pages	2
Journal	Nature Clinical Practice Gastroenterology and Hepatology
Volume	2
Issue number	2
DOIs	https://doi.org/10.1038/ncpgasthep0086
State	Published - Feb 1 2005

Keywords

Gastrointestinal stromal tumors
Imatinib
Progression-free survival

ASJC Scopus subject areas

Hepatology
Gastroenterology

Access to Document

10.1038/ncpgasthep0086

Cite this

@article{03c1a77a1938436fb8c9d4c248be17af,

title = "Low dose versus high dose imatinib for gastrointestinal stromal tumors",

keywords = "Gastrointestinal stromal tumors, Imatinib, Progression-free survival",

author = "J. Verweij and C. Blanke",

year = "2005",

month = feb,

day = "1",

doi = "10.1038/ncpgasthep0086",

language = "English (US)",

volume = "2",

pages = "76--77",

journal = "Nature Reviews Gastroenterology and Hepatology",

issn = "1759-5045",

publisher = "Nature Publishing Group",

number = "2",

}

TY - JOUR

T1 - Low dose versus high dose imatinib for gastrointestinal stromal tumors

AU - Verweij, J.

AU - Blanke, C.

PY - 2005/2/1

Y1 - 2005/2/1

KW - Gastrointestinal stromal tumors

KW - Imatinib

KW - Progression-free survival

UR - http://www.scopus.com/inward/record.url?scp=20344391372&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20344391372&partnerID=8YFLogxK

U2 - 10.1038/ncpgasthep0086

DO - 10.1038/ncpgasthep0086

M3 - Short survey

C2 - 16265122

AN - SCOPUS:20344391372

VL - 2

SP - 76

EP - 77

JO - Nature Reviews Gastroenterology and Hepatology

JF - Nature Reviews Gastroenterology and Hepatology

SN - 1759-5045

IS - 2

ER -